| Ident. | Authors (with country if any) | Title |
|---|
| 000A96 (2013) |
Annika Plate [Allemagne] ; Jens Benninghoff ; Gerald H. Jansen ; Elisabeth Wlasich ; Sabina Eigenbrod ; Alexander Drzezga ; Nathalie L. Jansen ; Hans A. Kretzschmar ; Kai Bötzel ; Dan Rujescu ; Adrian Danek | Atypical parkinsonism due to a D202N Gerstmann-Sträussler-Scheinker prion protein mutation: first in vivo diagnosed case. |
| 000B23 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000B96 (2012) |
Diego García-Borreguero [Espagne] ; Birgit Högl ; Luigi Ferini-Strambi ; John Winkelman ; Christina Hill-Zabala ; Afsaneh Asgharian ; Richard Allen | Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. |
| 001460 (2011) |
Mauro Manconi [Italie, Suisse] ; Raffaele Ferri [Italie] ; Marco Zucconi [Italie] ; Alessandro Oldani [Italie] ; Laura Giarolli [Italie] ; Valentina Bottasini [Italie] ; Luigi Ferini-Strambi [Italie] | Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome |
| 001983 (2010) |
Matthis Synofzik [Allemagne] ; Friedrich Asmus [Allemagne] ; Matthias Reimold [Allemagne] ; Ludger Schöls [Allemagne] ; Daniela Berg [Allemagne] | Sustained dopaminergic response of parkinsonism and depression in POLG‐associated parkinsonism |
| 001A23 (2010) |
M. K. Karvonen [Finlande] ; V. Kaasinen [Finlande] ; M. Korja [Finlande] ; R. J. Marttila [Finlande] | Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient |
| 001D25 (2010) |
Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis] | Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations |
| 002107 (2009) |
Andrew H. Evans [Australie] ; James R. Stegeman [Australie] | Punding in patients on dopamine agonists for restless leg syndrome |
| 002453 (2009) |
Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] | An open‐label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease |
| 002999 (2008) |
Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom |
| 002B03 (2007) |
Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] | Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader‐blinded monocenter echocardiography study |
| 002B44 (2007) |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 002B49 (2007) |
Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni] | Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease |
| 002B93 (2007) |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
| 002B94 (2007) |
Yoshikuni Mizuno [Japon] ; Takashi Abe [Japon] ; Kazuko Hasegawa [Japon] ; Sadako Kuno [Japon] ; Tomoyoshi Kondo [Japon] ; Mitsutoshi Yamamoto [Japon] ; Mitsuyoshi Nakashima [Japon] ; Ichiro Kanazawa [Japon] | Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study |
| 003062 (2007) |
Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni] | A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease |
| 003197 (2006) |
Jacques Montplaisir [Canada] ; Jeff Karrasch [Australie] ; Jean Haan [Allemagne] ; Dieter Volc [Autriche] | Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial |
| 003341 (2006) |
Anette Schrag [Royaume-Uni] ; Cristina Sampaio [Portugal] ; Nicholas Counsell [Royaume-Uni] ; Werner Poewe [Autriche] | Minimal clinically important change on the unified Parkinson's disease rating scale |
| 003589 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 003847 (2005) |
Robert M. Silva [États-Unis] ; Chia-Yi Kuan [États-Unis] ; Pasko Rakic [États-Unis] ; Robert E. Burke [États-Unis] | Mixed lineage kinase–c‐jun N‐terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease |
| 003924 (2005) |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
